Renovo is a privately held pharmacetutical company specializing in the commercialization of pharmaceutical cocrystals. Renovo identifies new, patentable, solid forms of active pharmaceutical ingredients (APIs) that can significantly improve the physical properties of the API. The primary focus of this effort is improving the bioavailability of poorly soluble APIs by incorporating high solubility cocrystals into a proprietary supersaturating drug delivery system.
View Top Employees from Renovo ResearchWebsite | http://renovoresearch.com |
Revenue | $4 million |
Employees | 1 (1 on RocketReach) |
Founded | 2008 |
Address | 749 Moreland Ave SE Ste A201, Atlanta, Georgia 30316, US |
Phone | (404) 377-7876 |
Technologies |
JavaScript,
Twitter,
G Suite
+5 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Competitors | Amedio CMC Consulting LLC, CMC Pharmaceuticals, Inc., Dow Development Laboratories, LLC (DDL), Velesco Pharmaceutical Services |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Renovo Research employee's phone or email?
The Renovo Research annual revenue was $4 million in 2023.
1 people are employed at Renovo Research.
Renovo Research is based in Atlanta, Georgia.
The NAICS codes for Renovo Research are [3254, 32541, 32, 325].
The SIC codes for Renovo Research are [28, 283].